The looming ‘patent cliff’ facing Big Pharma – Financial Times

  1. The looming ‘patent cliff’ facing Big Pharma  Financial Times
  2. Big Pharma prepare for next patent cliff as blockbuster drugs revenue losses loom: GlobalData  Express Pharma
  3. Pharma industry needs to pivot beyond generics | Policy Circle  policycircle.org
  4. Indian pharma eyes US gains as $63.7 bn patent cliff nears: Analysts  Business Standard

Continue Reading